EIR Pharmaceuticals
North America, Delaware, United States, Dover
Description
EIR Pharmaceuticals focuses on developing and commercializing health, wellness and pharmaceutical products for humans and animals.
Investor Profile
EIR Pharmaceuticals has made 1 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series A (100%)
Country Focus
- United States (100%)
Industry Focus
- Clinical Trials
- Health Care
- Medical
- Personal Development
- Psychology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
